Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases

Streetz, Konrad L., Tacke, Frank, Leifeld, Ludger, Wüstefeld, Torsten, Graw, Andrea, Klein, Christian, Kamino, Kenjii, Spengler, Ulrich, Kreipe, Hans, Kubicka, Stefan, Müller, Werner, Manns, Michael P., Trautwein, Christian·2003·Hepatology

Abstract

The contribution of the acute phase inducer interleukin 6 (IL–6) in the pathogenesis of liver diseases is yet unclear. Our analysis showed enhanced expression of IL–6 in livers derived from patients with acute and chronic liver diseases. Additionally, IL–6 plasma levels were significantly increased in patients with chronic liver diseases and showed an inverse correlation with biochemical markers of liver function and a positive correlation with inflammatory markers, signs of portal hypertension, and the degree of liver fibrosis. To prove the relevance of these clinical findings, we applied the tetrachlorcarbonide (CCl 4) model to conditional knockout animals (Cre/loxP system) for gp130, the common signal transducer of IL–6 family cytokines. Cre recombinases were expressed through a hepatocyte (AlfpCre) and a ubiquitous (MxCre) control element. Gp130 deleted mice had a totally abolished STAT3 activation and acute phase response induction, but gp130 deletion had no effect on the degree of acute liver injury and subsequent hepatocyte proliferation. In contrast, during chronic liver injury induced by biweekly application of CCl 4, deletion of the gp130 receptor in nonparenchymal liver cells and not hepatocytes resulted in fibrosis progression. In conclusion, our experiments indicate an involvement of IL–6 in the pathogenesis of liver diseases and suggest a protective role of IL–6/gp130–dependent pathways in nonparenchymal liver cells during fibrosis progression in chronic liver diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/jhep.2003.50268

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 167

Metadata

Authors
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., Müller, W., Manns, M. P., & Trautwein, C.
Venue
Hepatology
Published
2003-07
Volume
38
Issue
1
Pages
218-229
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2098193724
Cited by
167
References
8
FWCI
7.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases. https://app.cochat.ai/papers/10.1053/jhep.2003.50268
The paper
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., Müller, W., Manns, M. P., & Trautwein, C. (2003). Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases. Hepatology. https://doi.org/10.1053/jhep.2003.50268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.